Compare IT & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IT | FMS |
|---|---|---|
| Founded | 1979 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 13.9B |
| IPO Year | 1993 | 1996 |
| Metric | IT | FMS |
|---|---|---|
| Price | $231.46 | $22.00 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 10 | 2 |
| Target Price | ★ $309.67 | $30.00 |
| AVG Volume (30 Days) | ★ 823.6K | 599.4K |
| Earning Date | 02-03-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ 8.62 |
| EPS | ★ 11.49 | 2.86 |
| Revenue | $6,459,775,000.00 | ★ $23,046,819,198.00 |
| Revenue This Year | $6.71 | $2.13 |
| Revenue Next Year | $3.35 | $2.95 |
| P/E Ratio | $20.63 | ★ $14.61 |
| Revenue Growth | ★ 5.24 | 2.10 |
| 52 Week Low | $221.16 | $20.95 |
| 52 Week High | $584.01 | $30.46 |
| Indicator | IT | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 42.32 |
| Support Level | $221.16 | $20.96 |
| Resistance Level | $252.63 | $22.50 |
| Average True Range (ATR) | 8.14 | 0.49 |
| MACD | -1.52 | -0.09 |
| Stochastic Oscillator | 33.78 | 34.12 |
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.